IMPORTANT NOTE:
Your question is important to us and we will do our best to expedite a response. Multiple subject matter experts may be required to review a question to make sure our response is accurate and complete.

GuidanceGuidance

Guidance

CMS guidance documents related to Part C benefits policy.

Questions & Answers

Answers to previously asked questions.

Resources

Resources if your questions do not relate to Part C benefits policy.

Please review the available guidance documents and the resources below that may answer your question.

Contract Year 2023


Recent Regulations


Contract Year 2022


Other Reference Material

Answers to previously asked questions

Following are available resources if your questions do not relate to Part C benefits policy:

Questions specifically related to the Medicare FFS Average Sales Price (ASP) files may be directed to: Sec303ASPdata@cms.hhs.gov

If your question is regarding the Inflation Reduction Act, please submit the question to: IRARebateandNegotiation@cms.hhs.gov 

Policy related fiscal soundness questions, please submit an e-mail to: FinancialReview@cms.hhs.gov

Technical questions about the Out-of-Pocket Cost (OOPC) model, please submit an email to: OOPC@cms.hhs.gov

Part D benefits questions, please submit an email to: partdbenefits@cms.hhs.gov

Bid Pricing Tool (BPT) questions, please submit an email to: actuarial-bids@cms.hhs.gov

Medicare Medicaid Program, please submit an email to: mmcocapsmodel@cms.hhs.gov

Part C Medicare Advantage policy questions, please submit an inquiry via: https://dpap.lmi.org/DPAPMailbox/

Medicare Advantage Value-Based Insurance Design (MA-VBID) model questions, please submit an e-mail to: VBID@cms.hhs.gov

Appeals Policy questions, please submit inquiry via: https://appeals.lmi.org/

Enrollment and Eligibility Policy questions, please submit inquiry via: https://enrollment.lmi.org

 
Question

Ask a Part C Benefits Question

Please review the available guidance documents and resources described above before submitting a question.